Zobrazeno 1 - 10
of 327
pro vyhledávání: '"chronic heart disease"'
Autor:
Aldair Darlan Santos-de-Araújo, Daniela Bassi-Dibai, Izadora Moraes Dourado, Cássia da Luz Goulart, Renan Shida Marinho, Jaqueline de Almeida Mantovani, Gabriela Silva de Souza, Polliana Batista dos Santos, Meliza Goi Roscani, Shane A. Phillips, Audrey Borghi-Silva
Publikováno v:
Diabetology & Metabolic Syndrome, Vol 16, Iss 1, Pp 1-12 (2024)
Abstract Background Type 2 diabetes mellitus (T2DM) and chronic heart failure (CHF) present a decrease in functional capacity due to the intrinsic nature of both pathologies. It is not known about the potential impact of T2DM on functional capacity w
Externí odkaz:
https://doaj.org/article/9a82f16913ed4fd18c53095b4bfa2f5c
Autor:
Ganesh Yenurkar, Sandip Mal, Vincent O. Nyangaresi, Shailesh Kamble, Lalit Damahe, Nandkishor Bankar
Publikováno v:
Diagnostics, Vol 14, Iss 12, p 1297 (2024)
Chronic heart disease (CHD) is a widespread and persistent health challenge that demands immediate attention. Early detection and accurate diagnosis are essential for effective treatment and management of this condition. To overcome this difficulty,
Externí odkaz:
https://doaj.org/article/8749664a4b4a4a7aabf8b983b1260a3e
Akademický článek
Tento výsledek nelze pro nepřihlášené uživatele zobrazit.
K zobrazení výsledku je třeba se přihlásit.
K zobrazení výsledku je třeba se přihlásit.
Autor:
Yuming Wang, Xue Li, Min Qi, Xiaokai Li, Fangfang Zhang, Yuyu Wang, Junke Wu, Lexin Shu, Simiao Fan, Yunfei Li, Yubo Li
Publikováno v:
Frontiers in Molecular Biosciences, Vol 10 (2023)
Introduction: YiYiFuZi powder (YYFZ) is a classical formula in Chinese medicine, which is commonly used clinically for the treatment of Chronic Heart Disease (CHD), but it’s pharmacological effects and mechanism of action are currently unclear.Meth
Externí odkaz:
https://doaj.org/article/1c591c3e7b7a4888b9deae414cb1971e
Publikováno v:
Frontiers in Psychiatry, Vol 14 (2023)
Externí odkaz:
https://doaj.org/article/a25b3cb7db054933a90ef873c42958c7
Autor:
Cesare de Gregorio, Antonino Di Franco, Antonio Vittorio Panno, Marco Di Franco, Giuseppe Scaccianoce, Francesca Campanella, Giuseppina Novo, Alfredo Ruggero Galassi, Salvatore Novo, the SAFARI Study Group
Publikováno v:
Journal of Cardiovascular Development and Disease, Vol 10, Iss 8, p 336 (2023)
Background: The detection of subclinical/silent atrial fibrillation (SAF) in the general population is of the utmost importance, given its potential adverse consequences. Incident AF has been observed in 30% to 70% of patients with implanted devices,
Externí odkaz:
https://doaj.org/article/9c19f53b3c1d43c582cb0dd5324b3c3a
Publikováno v:
Clinics and Practice, Vol 11, Iss 1, Pp 81-91 (2021)
The virus that causes COVID-19 is rapidly spreading across the globe. Elderly patients with multiple pre-existing conditions are at a higher risk. This case study describes acute inpatient treatment of a COVID-19 patient with uncontrolled diabetes me
Externí odkaz:
https://doaj.org/article/dfe85839c67745c380517793695147db
Autor:
Monalisa Subudhi, P A T. Jagatheeswary, Susanta Kumar Sahu, Sudhanshu Kumar Das, K B Subudhi, Rashmi Ranjan Rout
Publikováno v:
Journal of Applied Hematology, Vol 12, Iss 3, Pp 140-146 (2021)
INTRODUCTION: Sickle cell anemia is a genetic hereditary disorder, with multifactorial cause for increase susceptibility, to bacterial infection leading to more intensive care unit (ICU) admission, morbidity, and mortality. When it is superadded by m
Externí odkaz:
https://doaj.org/article/07179fd569ac47ff96e716fe27ce482b
Autor:
Armando Stefanati, Silvia Lupi, Gianluca Campo, Silvia Cocchio, Patrizia Furlan, Vincenzo Baldo, Giovanni Gabutti
Publikováno v:
Archives of Public Health, Vol 78, Iss 1, Pp 1-14 (2020)
Abstract Background Seasonal influenza epidemics yearly affects 5–15% of the world’s population, resulting in 3–5 million serious cases and up to 650,000 deaths. According to the 2017–2019 Italian National Immunisation Plan, free immunisation
Externí odkaz:
https://doaj.org/article/37bf066763a3452aba5a75adf7c2b9cf
Autor:
D.D. Ivanov
Publikováno v:
Počki, Vol 9, Iss 1, Pp 35-38 (2020)
Today, torasemide is the most prescribed loop diuretic in clinical practice. Its high doses are used mainly in two clinical situations accompanied by hyperhydration: chronic heart failure (CHD) and chronic kidney disease (CKD). The latest guidelines
Externí odkaz:
https://doaj.org/article/103631d1fdbe40a49d589722a58315dd